NexImmune
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NexImmune generated cash of -$31,430,396, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$31,474,888.
Cash Flow
| 2018 | -11.11M | -12.64M | 9.18M |
|---|---|---|---|
| 2019 | -19.41M | 9.42M | 18.76M |
| 2020 | -26.40M | 221.93K | 22.08M |
| 2021 | -45.78M | -53.80M | 124.88M |
| 2022 | -51.19M | 50.31M | 5.17M |
| 2023 | -31.43M | -44.49K | 0 |
NEXI Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 34.69M | 30.39M | 5.09M | 9.19M | 425.99K | 15.00M |
Operating activities | ||||||
Net income | -32.34M | -62.50M | -50.90M | -29.86M | -20.54M | -12.83M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 1.02B | 994.79K | 870.28K | 618.99K | 436.36K | 204.64K |
Stock-based compensation expense | 3.55M | 5.87M | 5.97M | 1.21M | 1.53M | 0 |
| Deferred income tax benefit | 3.55M | 5.87M | 5.97M | 1.21M | 1.53M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.04M | 1.38M | -1.00M | 702.47K | 235.11K | 191.95K |
Cash generated by operating activities | -31.43M | -51.19M | -45.78M | -26.40M | -19.41M | -11.11M |
Investing activities | ||||||
Purchases Of Investments | 0 | -21.50M | -90.45M | 0 | -7.07M | -17.61M |
Investments In Property Plant And Equipment | -48.72K | -1.25M | -2.35M | -864.65K | -1.24M | -937.76K |
Acquisitions Net | 0 | 80.8K | -32.06M | 0 | 0 | 0 |
Cash generated by investing activities | -44.49K | 50.31M | -53.80M | 221.93K | 9.42M | -12.64M |
Financing activities | ||||||
Common Stock Issued | 0 | 5.14M | 114.72M | 6.60K | 18.78M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -12.26K | -19.88K | -18.43K | -7.27K |
Cash used in financing activities | 0 | 5.17M | 124.88M | 22.08M | 18.76M | 9.18M |
Net Change In Cash | -31.47M | 4.30M | 25.29M | -4.09M | 8.77M | -14.57M |
Cash at end of period | 3.22M | 34.69M | 30.39M | 5.09M | 9.19M | 425.99K |
| Data source | Data source | Data source | Data source |